Durham, NC, United States of America

Douglas Byron Sherman

USPTO Granted Patents = 21 

 

Average Co-Inventor Count = 3.9

ph-index = 7

Forward Citations = 234(Granted Patents)


Location History:

  • Gold Hill, OR (US) (2005)
  • Franklin Lakes, NJ (US) (2019)
  • Durham, NC (US) (2001 - 2023)

Company Filing History:


Years Active: 2001-2023

where 'Filed Patents' based on already Granted Patents

21 patents (USPTO):

Title: Innovations and Contributions of Douglas Byron Sherman

Introduction: Douglas Byron Sherman is a notable inventor based in Durham, NC, who has made significant contributions to the field of pharmaceuticals and medical devices. With a remarkable portfolio of 20 patents, Sherman's work primarily focuses on advancements that enhance the efficacy and safety of insulin delivery systems and related pharmaceutical preparations.

Latest Patents: Among his latest innovations, Sherman has developed a filter designed for reducing phenolic compounds from insulin and related infusion and injection devices. This invention addresses the critical need to remove preservatives, excipients, and stabilizers from pharmaceutical products while maintaining the concentration of the active compound. The devices, systems, and methods incorporated in this patent significantly improve the quality and safety of insulin preparations.

Another noteworthy patent involves photostable fluorescent polymeric tandem dyes, which include a water-soluble light harvesting multichromophore linked to luminescent metal complexes. This innovation holds promise in enhancing diagnostic techniques by allowing for effective evaluation of samples for target analytes, along with methods for labeling specific target molecules.

Career Highlights: Douglas Byron Sherman has had a distinguished career, working for major companies such as Becton Dickinson and Glaxo Wellcome. His experience in these well-respected organizations has undoubtedly contributed to his innovative projects, leading to significant advancements in medical technology and pharmaceuticals.

Collaborations: Throughout his career, Sherman has had the pleasure of collaborating with talented individuals, including J. Bruce Pitner and Terry J. Amiss. These collaborations have facilitated the development of pioneering solutions and have emphasized the importance of teamwork in driving innovation.

Conclusion: Douglas Byron Sherman's commitment to pioneering advancements in pharmaceutical technologies reflects his dedication to improving health outcomes through innovation. His extensive portfolio of patents and collaboration with esteemed colleagues underscore his status as a leading inventor in his field. As the industry continues to evolve, his contributions will likely have a lasting impact on the safety and efficacy of medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…